These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

412 related items for PubMed ID: 9563849

  • 21. Herpes simplex virus type 1 infection imposes a G(1)/S block in asynchronously growing cells and prevents G(1) entry in quiescent cells.
    Ehmann GL, McLean TI, Bachenheimer SL.
    Virology; 2000 Feb 15; 267(2):335-49. PubMed ID: 10662629
    [Abstract] [Full Text] [Related]

  • 22. Transcriptional control of the Htf9-A/RanBP-1 gene during the cell cycle.
    Di Matteo G, Fuschi P, Zerfass K, Moretti S, Ricordy R, Cenciarelli C, Tripodi M, Jansen-Durr P, Lavia P.
    Cell Growth Differ; 1995 Oct 15; 6(10):1213-24. PubMed ID: 8845298
    [Abstract] [Full Text] [Related]

  • 23. Transcriptional repression of the E2F-1 gene by interferon-alpha is mediated through induction of E2F-4/pRB and E2F-4/p130 complexes.
    Furukawa Y, Iwase S, Kikuchi J, Nakamura M, Yamada H, Matsuda M.
    Oncogene; 1999 Mar 18; 18(11):2003-14. PubMed ID: 10208422
    [Abstract] [Full Text] [Related]

  • 24. The retinoblastoma gene family members pRB and p107 coactivate the AP-1-dependent mouse tissue factor promoter in fibroblasts.
    Liu SL, Rand A, Kelm RJ, Getz MJ.
    Oncogene; 2000 Jul 13; 19(30):3352-62. PubMed ID: 10918592
    [Abstract] [Full Text] [Related]

  • 25. Role of pRB-family/E2F complex in the inhibition of IL-3-dependent lymphoid cell proliferation.
    Yamada M, Kondo T, Ashizawa S, Takebayashi T, Higashi H, Hatakeyama M.
    Cytokine; 2002 Jan 21; 17(2):91-7. PubMed ID: 11886176
    [Abstract] [Full Text] [Related]

  • 26. Two cytodifferentiation agent-induced pathways, differentiation and apoptosis, are distinguished by the expression of human papillomavirus 16 E7 in human bladder carcinoma cells.
    Richon VM, Russo P, Venta-Perez G, Cordon-Cardo C, Rifkind RA, Marks PA.
    Cancer Res; 1997 Jul 01; 57(13):2789-98. PubMed ID: 9205091
    [Abstract] [Full Text] [Related]

  • 27. pRB and p107 have distinct effects when expressed in pRB-deficient tumor cells at physiologically relevant levels.
    Jiang H, Karnezis AN, Tao M, Guida PM, Zhu L.
    Oncogene; 2000 Aug 10; 19(34):3878-87. PubMed ID: 10951581
    [Abstract] [Full Text] [Related]

  • 28. E2F/p107 and E2F/p130 complexes are regulated by C/EBPalpha in 3T3-L1 adipocytes.
    Timchenko NA, Wilde M, Iakova P, Albrecht JH, Darlington GJ.
    Nucleic Acids Res; 1999 Sep 01; 27(17):3621-30. PubMed ID: 10446255
    [Abstract] [Full Text] [Related]

  • 29. The family of retinoblastoma proteins.
    Stiegler P, Giordano A.
    Crit Rev Eukaryot Gene Expr; 2001 Sep 01; 11(1-3):59-76. PubMed ID: 11693966
    [Abstract] [Full Text] [Related]

  • 30. Expression patterns of retinoblastoma and E2F family proteins during corneal development.
    Francesconi CM, Hutcheon AE, Chung EH, Dalbone AC, Joyce NC, Zieske JD.
    Invest Ophthalmol Vis Sci; 2000 Apr 01; 41(5):1054-62. PubMed ID: 10752941
    [Abstract] [Full Text] [Related]

  • 31. Functional interplay between p53 and E2F through co-activator p300.
    Lee CW, Sørensen TS, Shikama N, La Thangue NB.
    Oncogene; 1998 May 28; 16(21):2695-710. PubMed ID: 9652736
    [Abstract] [Full Text] [Related]

  • 32. Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter.
    Araki K, Nakajima Y, Eto K, Ikeda MA.
    Oncogene; 2003 Oct 23; 22(48):7632-41. PubMed ID: 14576826
    [Abstract] [Full Text] [Related]

  • 33. RBP1 induces growth arrest by repression of E2F-dependent transcription.
    Lai A, Marcellus RC, Corbeil HB, Branton PE.
    Oncogene; 1999 Mar 25; 18(12):2091-100. PubMed ID: 10321733
    [Abstract] [Full Text] [Related]

  • 34.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 35.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 36. Retinoblastoma-related p107 and pRb2/p130 proteins in malignant lymphomas: distinct mechanisms of cell growth control.
    Leoncini L, Bellan C, Cossu A, Claudio PP, Lazzi S, Cinti C, Cevenini G, Megha T, Laurini L, Luzi P, Orcioni GF, Piccioli M, Pileri S, Giardino C, Tosi P, Giordano A.
    Clin Cancer Res; 1999 Dec 25; 5(12):4065-72. PubMed ID: 10632341
    [Abstract] [Full Text] [Related]

  • 37.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 38.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 39.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 40.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 21.